MENU
+Compare
ATAI
Stock ticker: NASDAQ
AS OF
May 9 closing price
Price
$1.39
Change
-$0.01 (-0.71%)
Capitalization
277.72M

ATAI ATAI Life Sciences NV Forecast, Technical & Fundamental Analysis

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes... Show more

ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ATAI with price predictions
May 09, 2025

ATAI sees its Stochastic Oscillator recovers from oversold territory

On May 09, 2025, the Stochastic Oscillator for ATAI moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 63 instances where the indicator left the oversold zone. In of the 63 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for ATAI crossed bullishly above the 50-day moving average on May 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATAI advanced for three days, in of 209 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ATAI as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ATAI turned negative on May 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

ATAI moved below its 50-day moving average on May 06, 2025 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for ATAI moved below the 200-day moving average on May 09, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATAI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ATAI entered a downward trend on April 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATAI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.388) is normal, around the industry mean (14.703). P/E Ratio (0.000) is within average values for comparable stocks, (64.016). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.990). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (714.286) is also within normal values, averaging (254.016).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ATAI is expected to report earnings to fall 33.79% to -15 cents per share on May 20

ATAI Life Sciences NV ATAI Stock Earnings Reports
Q1'25
Est.
$-0.16
Q4'24
Missed
by $0.09
Q3'24
Est.
$-0.16
Q2'24
Missed
by $0.20
Q1'24
Beat
by $0.01
The last earnings report on March 17 showed earnings per share of -23 cents, missing the estimate of -15 cents. With 1.08M shares outstanding, the current market capitalization sits at 277.72M.
A.I.Advisor
published Dividends

ATAI paid dividends on August 24, 2018

ATAI Life Sciences NV ATAI Stock Dividends
А annual dividend of $1.50 per share was paid with a record date of August 24, 2018, and an ex-dividend date of August 27, 2018. Read more...
A.I. Advisor
published General Information

General Information

a provider of computer-based testing services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Miscellaneous Commercial Services
Address
Wallstrasse 16
Phone
+49 8921539035
Employees
88
Web
https://www.atai.life
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMDSX19.820.04
+0.20%
Baird Mid Cap Growth Investor
JIVZX28.82N/A
N/A
JPMorgan U.S. Applied Data Sci Val R2
DHLTX22.66-0.02
-0.09%
Diamond Hill Select I
ATHDX27.99-0.04
-0.14%
American Century Heritage R6
RYRRX48.71-0.09
-0.18%
Rydex Russell 2000 A

ATAI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-0.71%
MNMD - ATAI
51%
Loosely correlated
-4.80%
CRSP - ATAI
47%
Loosely correlated
-1.44%
RXRX - ATAI
47%
Loosely correlated
-1.37%
ABCL - ATAI
47%
Loosely correlated
+1.00%
CYBN - ATAI
46%
Loosely correlated
+6.33%
More